USRM Posts Profitable Results for Second Quarter 2018
SUNRISE, FL – August 8, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
‘Renewing Our Heroes’ to Provide USRM Stem Cell Protocol to First Responders
SUNRISE, FL – June 5, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
USRM Chief Science Officer to Present at Fifth Annual Cell Surgical World Conference
SUNRISE, FL – June 1, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
USRM Chief Scientist Talks Stem Cell Journey, Autologous Stem Cells with ‘Something Significant’ Happy Living Podcast
SUNRISE, FL – May 17, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
World Bodybuilding Expert Interviews USRM Chief Science Officer At Paleo F(X) Conference
SUNRISE, FL – May 15, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
Autologous Stem Cell Therapy May Hold Key to Regeneration
USRM Chief Science Officer’s Live Webinar Adds Voice to Debate SUNRISE, FL – May 14, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary,…
U.S. Department of Justice Files Lawsuit at Request of FDA to Stop U.S. Stem Cell Clinic from Performing Autologous Stem Cell Procedure
USRM Will Vigorously Defend Medical Freedom of Americans SUNRISE, FL – May 9, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a world leader in the development of proprietary, physician-based…
U.S. Stem Cell Reports First Quarter Results
SUNRISE, FL – May 9, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
USRM Chief Science Officer to Host Webinar on Autologous Stem Cell Therapy
MIAMI, FL – May 8, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
USRM Chief Science Officer Featured in Live Interview for Biohacker Summit in Helsinki
MIAMI, FL – May 3, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, announced…
Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales
SUNRISE, FL – April 24, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced…
USRM Announces 2017 Financial Results
SUNRISE, FL – April 16, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…